IBT
International Biotechnology Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $8.91M | Buy |
250,052
+170,000
| +212% | +$6.06M | 3% | 11 |
|
|
2023
Q2 | $3.69M | Sell |
80,052
-184,000
| -70% | -$8.48M | 1.12% | 27 |
|
|
2023
Q1 | $10.6M | Buy |
264,052
+90,000
| +52% | +$3.61M | 2.95% | 8 |
|
|
2022
Q4 | $8.06M | Hold |
174,052
| – | – | 2.49% | 15 |
|
|
2022
Q3 | $7.2M | Buy |
174,052
+164,442
| +1,711% | +$6.8M | 2.31% | 15 |
|
|
2022
Q2 | $161K | Sell |
9,610
-223,490
| -96% | -$3.75M | 1.68% | 19 |
|
|
2022
Q1 | $2.07M | Buy |
233,100
+95,000
| +69% | +$845K | 0.47% | 43 |
|
|
2021
Q4 | $11.6M | Buy |
138,100
+35,000
| +34% | +$2.94M | 2.59% | 13 |
|
|
2021
Q3 | $9.29M | Buy |
103,100
+43,000
| +72% | +$3.87M | 2.24% | 14 |
|
|
2021
Q2 | $5.73M | Buy |
60,100
+40,000
| +199% | +$3.81M | 1.51% | 21 |
|
|
2021
Q1 | $2.29M | Buy |
+20,100
| New | +$2.29M | 0.6% | 31 |
|
|
2018
Q2 | – | Sell |
-41,000
| Closed | -$2.09M | – | 61 |
|
|
2018
Q1 | $2.09M | Buy |
+41,000
| New | +$2.09M | 0.82% | 30 |
|